Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development | White Papers
Search Refinements

Drug Discovery & Development White Papers

View white papers from other Pharmaceutical sectors:
1-15 of 147 results
Vetter Development Service Chicago
| By Vetter Pharma International
Our premium manufacturing and clinical supply site near Chicago, Illinois, has the people, processes, and technology to serve pharma and biotech companies of every size with customizable solutions for drug compounds in any stage from Preclinical Testing to Phase II and beyond.
Drug Research > Drug Discovery & Development > White Papers
Vetter-Ject® Syringe Closure System
| By Vetter Pharma International
Today’s complex, sensitive biologic compounds demand new, innovative delivery systems. The Vetter-Ject® closure system allows you to offer the convenience of a syringe in a design that addresses the unique requirements of highly sensitive compounds.
Drug Research > Drug Discovery & Development > White Papers
SYSTAG: The use of FlexyPAT-HFC for calorimetric measurements
| By SYSTAG
FlexyPAT is a modular Process Automation Technology that enables automated customer-specific lab reactor systems to be implemented in a very cost-effective manner, including with the integration of existing devices.
Drug Research > Drug Discovery & Development > White Papers
SYSTAG: Efficient synthesis development
| By SYSTAG
Efficient synthesis development using the example of determi-nation of the metastable zone.
Drug Research > Drug Discovery & Development > White Papers
Softigel introduces new energy gummies at vitafoods
| By Softigel pbr
Who hasn´t needed a wake-me-up in the morning or hasn´t dragged a tired body to the end of the day? Regardless how we individually spend our day, the intensity of our routine, the sports practice or the stressful of our labor; the common consequence is the high demand and lack of energy.
Drug Research > Drug Discovery & Development > White Papers
FlexyPlant – Scale-Up Application Example from the Pharmaceutical Industry
| By SYSTAG
Scale-up by a factor of 300; from 70ml reactor into 25lt pilot plant. A scale-up step by factor 300 takes place in different laboratories, in fully diversified plants mostly. A great deal of information may be lost, and the knowledge of development Chemists can not be implemented optimally.
Drug Research > Drug Discovery & Development > White Papers
Optimizing Development Resources for Efficient Product Development
| By SYSTAG
Nowadays, efficient process research and development are, more than ever, an absolute must for contract manufacturers and API manufacturers. New products/processes need to be pushed through to market readiness faster and faster.
Drug Research > Drug Discovery & Development > White Papers
A Survival Guide to Temperature Data in Life Sciences, by Almac
| By Almac
Regulations continue to evolve globally within the distribution arena of the Life Sciences industry. Good Distribution Practice of Medicinal Products for Human Use (2013/C 343/01)1 as well as Good Distribution Practices Supply Chain Integrity2 has made the most significant impact. There is an increased focus on companies being able to prove the quality and integrity of their drug product throughout the entire supply chain. The industry is facing stricter compliance demands from regulations and regulatory agencies are not always given clear guidance.
Drug Research > Drug Discovery & Development > White Papers
Almac: Changing the Dynamics of Temperature Controlled Shipping Solutions
| By Almac
In the typical clinical trial today, the cost of shipping and distributing supplies accounts for approximately 60 percent of the overall clinical supply chain. And when the cost of product spoilage from temperature excursions is added into the mix, it is no wonder that pharmaceutical companies, Clinical Research Organizations (CROs), and logistics vendors are all eagerly searching for efficiencies and ways to carve costs out of the process.
Drug Research > Drug Discovery & Development > White Papers
Almac Explores Interactive Response Technology: An Untapped Source of Historical and Real-Time Data for Risk-Based Monitoring
| By Almac
Risk-based monitoring has attracted the support of a diverse group of organisations in recent years. Regulators have released guidance encouraging the use of risk-based approaches to clinical trial quality, vendors have created technologies to support such methods, and large pharma companies have pooled their resources to drive adoption. Yet, despite this flurry of activity, the industry has overlooked a potentially useful source of real-time and historical data.
Drug Research > Drug Discovery & Development > White Papers
1-15 of 147 results